Barnes Dennig Private Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Barnes Dennig Private Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64.1K	Buy	405 +12	+3%	+$1.62K	0.05%	147
2026 Q1	$50.2K	Sell	393 -3	-0.8%	-$375	0.05%	144
2025 Q4	$48.3K	Buy	+396	New	+$45.4K	0.05%	148

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

Barnes Dennig Private Wealth Management's XBI Position: Q2 2026 in Review

Barnes Dennig Private Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.1% in Q2 2026, buying an estimated $1.62K and bringing the position to 405 shares worth $64.1K. The position accounts for 0.05% of the portfolio, ranked #147.

Barnes Dennig Private Wealth Management first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Barnes Dennig Private Wealth Management held 405 shares of State Street SPDR S&P Biotech ETF worth $64.1K as of Q2 2026.
Barnes Dennig Private Wealth Management bought 12 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.62K.
State Street SPDR S&P Biotech ETF made up 0.05% of Barnes Dennig Private Wealth Management's portfolio in Q2 2026, its #147 holding.
Barnes Dennig Private Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Barnes Dennig Private Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.